Form 8-K - Current report:
SEC Accession No. 0001193125-25-133268
Filing Date
2025-06-02
Accepted
2025-06-02 16:01:20
Documents
12
Period of Report
2025-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d945851d8k.htm   iXBRL 8-K 28869
  Complete submission text file 0001193125-25-133268.txt   140659

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stro-20250602.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20250602_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20250602_pre.xml EX-101.PRE 10814
14 EXTRACTED XBRL INSTANCE DOCUMENT d945851d8k_htm.xml XML 3502
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 251014789
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)